COR - Company ID 0001140859
Cencora, Inc. trades as COR and has a market capitalization of $58.85 B, making it the #281 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $321.33B, up 9.3% from the prior year and net income of $1.55B. This page tracks Cencora, Inc. through 2,538 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Cencora, Inc.'s revenue grew from $146.85B to $321.33B, a compound annual growth rate of 9.1%. Net profit margin compressed from 1.0% to 0.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| SCHEDULE 13G | - | 2026-04-29 |
| Insider trade | 4 | 2026-04-02 |
| SCHEDULE 13G/A | - | 2026-03-26 |
The largest companies sharing Cencora, Inc.'s SEC industry classification (wholesale-drugs, proprietaries & druggists' sundries).
Cencora, Inc. (COR) has a market capitalization of $58.85 B as of 2026-07-09, ranking #281 among US-listed companies.
Cencora, Inc. reported revenue of $321.33B for fiscal year 2025, an increase of 9.3% year over year.
Yes. Cencora, Inc. reported net income of $1.55B in its latest fiscal year.